These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 17229078)
61. Effect of interleukin-2 receptor antagonists on new-onset diabetes after liver transplantation: A retrospective cohort study. Xue M; Lv C; Chen X; Huang X; Sun Q; Wang T; Liang J; Zhang Y; He S; Gao J; Zhou J; Yu M; Fan J; Gao X J Diabetes; 2016 Jul; 8(4):579-87. PubMed ID: 26588180 [TBL] [Abstract][Full Text] [Related]
62. New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression. Luan FL; Steffick DE; Ojo AO Transplantation; 2011 Feb; 91(3):334-41. PubMed ID: 21242885 [TBL] [Abstract][Full Text] [Related]
63. Body fat percentage as a marker of new-onset diabetes mellitus after kidney transplantation. Tokodai K; Amada N; Kikuchi H; Haga I; Takayama T; Nakamura A Transplant Proc; 2013 May; 45(4):1544-7. PubMed ID: 23726616 [TBL] [Abstract][Full Text] [Related]
64. New-onset Diabetes after Renal Transplant and Associated Factors. Khan AA; Ahmed W; Ayyaz A J Coll Physicians Surg Pak; 2021 Dec; 31(12):1482-1486. PubMed ID: 34794292 [TBL] [Abstract][Full Text] [Related]
65. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Blüher M; Fasshauer M; Tönjes A; Kratzsch J; Schön MR; Paschke R Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):534-7. PubMed ID: 16235156 [TBL] [Abstract][Full Text] [Related]
66. Pretransplantation Risk Factors Associated With New-onset Diabetes After Living-donor Kidney Transplantation. Xie L; Tang W; Wang X; Wang L; Lu Y; Lin T Transplant Proc; 2016 Dec; 48(10):3299-3302. PubMed ID: 27931572 [TBL] [Abstract][Full Text] [Related]
67. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s). El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747 [TBL] [Abstract][Full Text] [Related]
68. The Utility of Pre- and Post-Transplant Oral Glucose Tolerance Tests: Identifying Kidney Transplant Recipients With or at Risk of New Onset Diabetes After Transplant. Singer J; Aouad LJ; Wyburn K; Gracey DM; Ying T; Chadban SJ Transpl Int; 2022; 35():10078. PubMed ID: 35368638 [No Abstract] [Full Text] [Related]
69. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians. Nayak BS; Ramsingh D; Gooding S; Legall G; Bissram S; Mohammed A; Raychaudhuri A; Sahadeo B; Pandohie V; Figaro K Prim Care Diabetes; 2010 Oct; 4(3):187-92. PubMed ID: 20580627 [TBL] [Abstract][Full Text] [Related]
70. Waist circumference as an independent risk factor for NODAT. Dedinská I; Laca Ľ; Miklušica J; Rosenberger J; Žilinská Z; Galajda P; Mokáň M Ann Transplant; 2015 Mar; 20():154-9. PubMed ID: 25791039 [TBL] [Abstract][Full Text] [Related]
71. High Serum PCSK9 Is Associated With Increased Risk of New-Onset Diabetes After Transplantation in Renal Transplant Recipients. Eisenga MF; Zelle DM; Sloan JH; Gaillard CAJM; Bakker SJL; Dullaart RPF Diabetes Care; 2017 Jul; 40(7):894-901. PubMed ID: 28461454 [TBL] [Abstract][Full Text] [Related]
72. Continuous glucose monitoring after kidney transplantation in non-diabetic patients: early hyperglycaemia is frequent and may herald post-transplantation diabetes mellitus and graft failure. Wojtusciszyn A; Mourad G; Bringer J; Renard E Diabetes Metab; 2013 Oct; 39(5):404-10. PubMed ID: 23999231 [TBL] [Abstract][Full Text] [Related]
74. Prevalence and Risk Factors of Abnormal Glucose Metabolism and New-Onset Diabetes Mellitus after Kidney Transplantation: A Single-Center Retrospective Observational Cohort Study. Alfieri C; Favi E; Campioli E; Cicero E; Molinari P; Campise M; Gandolfo MT; Regalia A; Cresseri D; Messa P; Castellano G Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363565 [No Abstract] [Full Text] [Related]
75. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus. Elens L; Sombogaard F; Hesselink DA; van Schaik RH; van Gelder T Pharmacogenet Genomics; 2013 Dec; 23(12):649-57. PubMed ID: 24113216 [TBL] [Abstract][Full Text] [Related]
76. Early occurrence of new-onset diabetes after transplantation is related to type of liver graft and warm ischaemic injury. Hartog H; May CJ; Corbett C; Phillips A; Tomlinson JW; Mergental H; Isaac J; Bramhall S; Mirza DF; Muiesan P; Perera MT Liver Int; 2015 Jun; 35(6):1739-47. PubMed ID: 25349066 [TBL] [Abstract][Full Text] [Related]
78. New-onset diabetes mellitus after renal transplantation. Goldmannova D; Karasek D; Krystynik O; Zadrazil J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):195-200. PubMed ID: 26927467 [TBL] [Abstract][Full Text] [Related]
79. Diagnostic Accuracies of Glycated Hemoglobin, Fructosamine, and Homeostasis Model Assessment of Insulin Resistance in Predicting Impaired Fasting Glucose, Impaired Glucose Tolerance, or New Onset Diabetes After Transplantation. Rosettenstein K; Viecelli A; Yong K; Nguyen HD; Chakera A; Chan D; Dogra G; Lim EM; Wong G; Lim WH Transplantation; 2016 Jul; 100(7):1571-9. PubMed ID: 26437275 [TBL] [Abstract][Full Text] [Related]
80. New-onset diabetes after transplantation: assessment of risk factors and clinical outcomes. Cotovio P; Neves M; Rodrigues L; Alves R; Bastos M; Baptista C; Macário F; Mota A Transplant Proc; 2013 Apr; 45(3):1079-83. PubMed ID: 23622631 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]